Additionally, targeting sphingosine kinase 1 (SPHK1) with its inhibitor MP-A08 induced ceramide accumulation, activated the downstream apoptotic integrated stress response, and sensitized AML cells to venetoclax. This evidence concerns the gene SPHK1 and acute myeloid leukemia.